Filing Details
- Accession Number:
- 0001140361-11-038161
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-27 16:05:32
- Reporting Period:
- 2011-07-25
- Filing Date:
- 2011-07-27
- Accepted Time:
- 2011-07-27 16:05:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1319606 | Andrew Miller | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-07-25 | 25,000 | $21.00 | 27,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-07-25 | 25,000 | $39.78 | 2,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-07-26 | 25,000 | $21.00 | 27,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-07-26 | 25,000 | $39.56 | 2,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-07-25 | 25,000 | $0.00 | 25,000 | $21.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-07-26 | 25,000 | $0.00 | 25,000 | $21.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 150,000 | 2018-04-14 | No | 4 | M | Direct | |
| 125,000 | 2018-04-14 | No | 4 | M | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 11, 2010.
- Represents the aggregate of sales effected on the same day at different prices.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $39.08 to $40.00 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer
- Represents the weighted average sales price per share. The shares sold at prices ranging from $39.53 to $39.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer
- 25% of the shares subject to the grant vested and became exercisable on April 18, 2009; thereafter, 2.0833% of the shares subject to the grant vested or will vest and become exercisable on each monthly anniversay of the First Vesting Date until 100% vested.
Billionaire Hedge Funds
